SI1814534T1 - Derivati aminolevulinske kisline za zdravljenjeaken - Google Patents

Derivati aminolevulinske kisline za zdravljenjeaken

Info

Publication number
SI1814534T1
SI1814534T1 SI200531079T SI200531079T SI1814534T1 SI 1814534 T1 SI1814534 T1 SI 1814534T1 SI 200531079 T SI200531079 T SI 200531079T SI 200531079 T SI200531079 T SI 200531079T SI 1814534 T1 SI1814534 T1 SI 1814534T1
Authority
SI
Slovenia
Prior art keywords
acne
treatment
aminolevulinic acid
derivatives
photosensitiser
Prior art date
Application number
SI200531079T
Other languages
English (en)
Slovenian (sl)
Inventor
Aslak Godal
Jo Klaveness
Hilde Morris
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of SI1814534T1 publication Critical patent/SI1814534T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Semiconductor Lasers (AREA)
SI200531079T 2004-11-10 2005-11-04 Derivati aminolevulinske kisline za zdravljenjeaken SI1814534T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0424833A GB0424833D0 (en) 2004-11-10 2004-11-10 Method
PCT/GB2005/004253 WO2006051269A1 (en) 2004-11-10 2005-11-04 Treatment of acne using derivatives of 5-aminolevulinic acid
EP05800149A EP1814534B1 (en) 2004-11-10 2005-11-04 Derivatives of 5-aminolevulinic acid for the treatment of acne

Publications (1)

Publication Number Publication Date
SI1814534T1 true SI1814534T1 (sl) 2010-09-30

Family

ID=33523497

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531079T SI1814534T1 (sl) 2004-11-10 2005-11-04 Derivati aminolevulinske kisline za zdravljenjeaken

Country Status (16)

Country Link
US (2) US20080188558A1 (https=)
EP (1) EP1814534B1 (https=)
JP (1) JP5134370B2 (https=)
CN (1) CN101056626B (https=)
AT (1) ATE469674T1 (https=)
AU (1) AU2005303565B2 (https=)
CA (1) CA2586195C (https=)
DE (1) DE602005021677D1 (https=)
DK (1) DK1814534T3 (https=)
ES (1) ES2344986T3 (https=)
GB (1) GB0424833D0 (https=)
PL (1) PL1814534T3 (https=)
PT (1) PT1814534E (https=)
RU (1) RU2385718C2 (https=)
SI (1) SI1814534T1 (https=)
WO (1) WO2006051269A1 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US20110224598A1 (en) * 2010-03-12 2011-09-15 Daniel Barolet Radiant near infrared light emitting diode exposure as skin preparation
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
KR100796450B1 (ko) * 2006-06-29 2008-01-22 전남대학교산학협력단 5-아미노레불린산의 불포화 알킬 에스터 및 약학적으로허용되는 그의 염, 이의 제조방법 및 이의 용도
GB0700580D0 (en) * 2007-01-11 2007-02-21 Photocure Asa Use
EP2644228A1 (en) 2007-06-27 2013-10-02 The General Hospital Corporation Method and apparatus for optical inhibition of photodynamic therapy
AU2008337067A1 (en) 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
GB0823265D0 (en) * 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
RU2526803C2 (ru) 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
CA2790827A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
AU2011293132C1 (en) 2010-08-27 2016-04-21 Sebacia, Inc. Compositions and methods for targeted thermomodulation
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
WO2012086802A1 (ja) 2010-12-24 2012-06-28 アークレイ株式会社 癌細胞の検出方法
KR101308652B1 (ko) * 2011-05-19 2013-09-13 제너럴바이오(주) Ｍａｌ을 이용한 여드름 치료 조성물
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2766049A1 (en) 2011-10-14 2014-08-20 Photocure ASA Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
WO2013092936A2 (en) * 2011-12-20 2013-06-27 Galderma Research & Development Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
CA2880422C (en) 2012-08-03 2021-02-09 Photocure Asa Derivatives of 5-aminolevulinic acid
WO2014026077A1 (en) * 2012-08-10 2014-02-13 Dusa Pharmaceuticals, Inc. Method for the treatment of acne
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
CA2887687A1 (en) 2012-10-11 2014-04-17 Nanocomposix, Inc. Silver nanoplate compositions and methods
JP2016507663A (ja) 2012-12-20 2016-03-10 コンバテック・テクノロジーズ・インコーポレイテッドＣｏｎｖａｔｅｃ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ 化学修飾セルロース系繊維の加工
KR101623553B1 (ko) * 2013-07-23 2016-05-23 동성제약주식회사 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
JP6595484B2 (ja) * 2013-12-20 2019-10-23 ガルデルマ・リサーチ・アンド・デヴェロップメント 光損傷皮膚のパルス光力学的処置
DK3091919T3 (da) * 2014-01-10 2025-01-02 Coronado Aesthetics Llc Behandlingsintervaller til brug af sammensætninger, der indeholder energiabsorberende materialer til dermatologiske anvendelser
US9956426B2 (en) 2015-02-26 2018-05-01 Amol Punjabi Upconverting nanoparticles
US20160287615A1 (en) * 2015-04-03 2016-10-06 BioPharmX, Inc. Novel encapsulation of fluorescent, photo-sensitive, or oxygen-sensitive active ingredient for topical application
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
EP3362145B1 (en) 2015-10-15 2021-01-06 DUSA Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
CN106801037B (zh) * 2017-01-06 2021-01-19 中国人民解放军南京军区福州总医院 体外痤疮炎症模型的建立方法及其应用
US10632324B2 (en) 2017-04-27 2020-04-28 9127-4910 Quebec Inc. Method for the treatment of skin tissues
US20200261580A1 (en) * 2017-07-17 2020-08-20 Andrea Willey Photodynamic Therapy Method for Skin Disorders
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
KR102171200B1 (ko) * 2018-11-20 2020-10-28 제너럴바이오(주) 5-아미노레불린산 수화염화물과 그 유도체를 유효성분으로 함유하는 여드름성 피부염 개선 또는 그의 조성물
KR102265592B1 (ko) * 2020-10-29 2021-06-17 김진왕 5-아미노레불린산 수화염화물을 포함하는 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5079262A (en) * 1989-07-28 1992-01-07 Queen's University At Kingston Method of detection and treatment of malignant and non-malignant lesions utilizing 5-aminolevulinic acid
US5955490A (en) * 1989-07-28 1999-09-21 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US5422093A (en) * 1989-07-28 1995-06-06 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5713845A (en) * 1991-10-29 1998-02-03 Thermolase Corporation Laser assisted drug delivery
FI951295A7 (fi) 1992-09-21 1995-05-17 Quadra Logic Tech Inc Ihon läpi tapahtuva veressä olevien valoherkkien aineiden in vivo-akti vointi
FR2714602B1 (fr) * 1993-12-30 1996-02-09 Oreal Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation.
ATE202076T1 (de) * 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
JPH1112197A (ja) 1997-06-18 1999-01-19 Cosmo Sogo Kenkyusho:Kk 悪性腫瘍診断剤及び治療剤
US6183773B1 (en) * 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
DE10003620A1 (de) 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
ATE463237T1 (de) * 2000-08-16 2010-04-15 Gen Hospital Corp Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
GB0118251D0 (en) 2001-07-26 2001-09-19 Photocure Asa Method
US20050090481A1 (en) * 2001-11-09 2005-04-28 Qlt Inc Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment
US20040048842A1 (en) * 2002-09-10 2004-03-11 Mcmillan Kathleen Method of treating skin disorders
US20050209331A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
US20050209330A1 (en) * 2004-03-22 2005-09-22 Syneron Medical Ltd. Method of treatment of skin
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds

Also Published As

Publication number Publication date
PT1814534E (pt) 2010-06-15
CN101056626A (zh) 2007-10-17
US8546447B2 (en) 2013-10-01
US20080188558A1 (en) 2008-08-07
DK1814534T3 (da) 2010-09-20
RU2007115601A (ru) 2008-12-20
CN101056626B (zh) 2011-12-14
CA2586195A1 (en) 2006-05-18
RU2385718C2 (ru) 2010-04-10
AU2005303565A1 (en) 2006-05-18
DE602005021677D1 (de) 2010-07-15
JP5134370B2 (ja) 2013-01-30
JP2008519812A (ja) 2008-06-12
US20130066256A1 (en) 2013-03-14
EP1814534B1 (en) 2010-06-02
EP1814534A1 (en) 2007-08-08
PL1814534T3 (pl) 2010-11-30
WO2006051269A1 (en) 2006-05-18
GB0424833D0 (en) 2004-12-15
ATE469674T1 (de) 2010-06-15
AU2005303565B2 (en) 2011-04-14
ES2344986T3 (es) 2010-09-13
CA2586195C (en) 2013-12-31

Similar Documents

Publication Publication Date Title
SI1814534T1 (sl) Derivati aminolevulinske kisline za zdravljenjeaken
WO2008020027A3 (en) 2,5-dihydroxybenzene compounds for the treatment of skin cancer
IL189694A0 (en) Biphenyl derivatives and their use in treating hepatitis c
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MX374396B (es) Rocio de fentanilo sublingual.
WO2008075068A3 (en) Acylaminopyrazoles as fgfr inhibitors
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
WO2007087395A3 (en) UNSATURATED mTOR INHIBITORS
AU2003210428A1 (en) Phenethanolamine derivatives for treatment of respiratory diseases
ZA200806778B (en) N-Hydroxyacrylamide compounds
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
MX2009005247A (es) Metodos para mejorar la biodisponibilidad de un inhibidor de renina.
WO2006133231A3 (en) Treatment for neurodegenerative diseases
IL179813A0 (en) S-tenatoprazole sodium monohydrate salt and use thereof in the form of a proton pump inhibitor
WO2004069998A3 (en) Oxindole derivatives as antimicrobial agents
AU2003216965A1 (en) Compounds, particularly of urea derivatives or ester derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases
GB0229022D0 (en) Organic Compounds
AU2003267751A1 (en) Use of epothilone derivatives for the treatment of hyperparathyroidism
WO2008149971A1 (ja) 脳動脈瘤の治療または予防薬
WO2007063509A8 (en) Phosphocreatine complexes
CY1110563T1 (el) Παραγωγο του ισοξαζολικου οξεος για την ανακουφιση νευροπαθητικου πονου
MXPA03010920A (es) Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia.
WO2004035031A3 (en) Treatment of uveal melanoma